90 related articles for article (PubMed ID: 12054478)
21. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
[TBL] [Abstract][Full Text] [Related]
22. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
Wetzel M; Premkumar DR; Arnold B; Pollack IF
J Neurosurg; 2005 Dec; 103(6 Suppl):549-56. PubMed ID: 16383255
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
Baradari V; Huether A; Höpfner M; Schuppan D; Scherübl H
Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768
[TBL] [Abstract][Full Text] [Related]
24. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
25. Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements.
Katula KS; Wright KL; Paul H; Surman DR; Nuckolls FJ; Smith JW; Ting JP; Yates J; Cogswell JP
Cell Growth Differ; 1997 Jul; 8(7):811-20. PubMed ID: 9218875
[TBL] [Abstract][Full Text] [Related]
26. The inhibition of cyclin B1 gene transcription in quiescent NIH3T3 cells is mediated by an E-box.
Farina A; Gaetano C; Crescenzi M; Puccini F; Manni I; Sacchi A; Piaggio G
Oncogene; 1996 Sep; 13(6):1287-96. PubMed ID: 8808703
[TBL] [Abstract][Full Text] [Related]
27. Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells.
Yu Z; Kone BC
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F496-502. PubMed ID: 16174862
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.
Alao JP; Lam EW; Ali S; Buluwela L; Bordogna W; Lockey P; Varshochi R; Stavropoulou AV; Coombes RC; Vigushin DM
Clin Cancer Res; 2004 Dec; 10(23):8094-104. PubMed ID: 15585645
[TBL] [Abstract][Full Text] [Related]
29. The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases.
Tabruyn SP; Nguyen NQ; Cornet AM; Martial JA; Struman I
Mol Endocrinol; 2005 Jul; 19(7):1932-42. PubMed ID: 15746189
[TBL] [Abstract][Full Text] [Related]
30. E2Fs link the control of G1/S and G2/M transcription.
Zhu W; Giangrande PH; Nevins JR
EMBO J; 2004 Nov; 23(23):4615-26. PubMed ID: 15510213
[TBL] [Abstract][Full Text] [Related]
31. Effects of trichostatin A on neuronal mu-opioid receptor gene expression.
Lin YC; Flock KE; Cook RJ; Hunkele AJ; Loh HH; Ko JL
Brain Res; 2008 Dec; 1246():1-10. PubMed ID: 18950606
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression.
Pan L; Lu J; Wang X; Han L; Zhang Y; Han S; Huang B
Cancer; 2007 Apr; 109(8):1676-88. PubMed ID: 17330857
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts.
Chen JS; Faller DV
J Cell Physiol; 2005 Jan; 202(1):87-99. PubMed ID: 15389542
[TBL] [Abstract][Full Text] [Related]
35. Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells.
Fan X; Roy EM; Murphy TC; Nanes MS; Kim S; Pike JW; Rubin J
J Cell Biochem; 2004 Nov; 93(4):807-18. PubMed ID: 15389882
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
[TBL] [Abstract][Full Text] [Related]
37. Mouse epidermal stem cells proceed through the cell cycle.
Dunnwald M; Chinnathambi S; Alexandrunas D; Bickenbach JR
J Cell Physiol; 2003 May; 195(2):194-201. PubMed ID: 12652646
[TBL] [Abstract][Full Text] [Related]
38. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
[TBL] [Abstract][Full Text] [Related]
39. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells.
Hernandez M; Shao Q; Yang XJ; Luh SP; Kandouz M; Batist G; Laird DW; Alaoui-Jamali MA
Prostate; 2006 Aug; 66(11):1151-61. PubMed ID: 16652385
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
